Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Southwick

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
The Journal of Urology|September 24, 1999
Prediction of post-radical prostatectomy pathological outcome for stage T1c prostate cancer with percent free prostate specific antigen: a prospective multicenter clinical trialP C Southwick, W J Catalona, A W Partin, et al.
Urology|August 5, 2000
Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and stagingW J Catalona, P C Southwick, K M Slawin, et al.
Urology|March 4, 2000
Percentage of free PSA in black versus white men for detection and staging of prostate cancer: a prospective multicenter clinical trialW J Catalona, A W Partin, K M Slawin, et al.
JAMA|May 30, 1998
Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trialW J Catalona, A W Partin, K M Slawin, et al.
Nature and Science of Sleep|June 27, 2018
Use of blood biomarkers to screen for obstructive sleep apneaWesley Elon Fleming, Jon-Erik C Holty, Richard K Bogan, et al.
Clinical Biochemistry|September 28, 2014
Absolute and relative changes (delta) in troponin I for early diagnosis of myocardial infarction: Results of a prospective multicenter trialAlan B Storrow, Richard M Nowak, Deborah B Diercks, et al.
Clinical Chemistry|October 3, 1999
Analytical and clinical performance characteristics of Hybritech's Tandem-R free PSA assay during a large multicenter clinical trial to determine the clinical utility of percentage of free prostate-specific antigenD W Chan, C A Kelley, T L Ratliff, et al.
Clinical Biochemistry|September 8, 2014
Diagnostic performance of cardiac Troponin I for early rule-in and rule-out of acute myocardial infarction: Results of a prospective multicenter trialAlan B Storrow, Robert H Christenson, Richard M Nowak, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
The Journal of Urology|September 24, 1999
Prediction of post-radical prostatectomy pathological outcome for stage T1c prostate cancer with percent free prostate specific antigen: a prospective multicenter clinical trialP C Southwick, W J Catalona, A W Partin, et al.
Urology|August 5, 2000
Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and stagingW J Catalona, P C Southwick, K M Slawin, et al.
Urology|March 4, 2000
Percentage of free PSA in black versus white men for detection and staging of prostate cancer: a prospective multicenter clinical trialW J Catalona, A W Partin, K M Slawin, et al.
JAMA|May 30, 1998
Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trialW J Catalona, A W Partin, K M Slawin, et al.
Nature and Science of Sleep|June 27, 2018
Use of blood biomarkers to screen for obstructive sleep apneaWesley Elon Fleming, Jon-Erik C Holty, Richard K Bogan, et al.
Clinical Biochemistry|September 28, 2014
Absolute and relative changes (delta) in troponin I for early diagnosis of myocardial infarction: Results of a prospective multicenter trialAlan B Storrow, Richard M Nowak, Deborah B Diercks, et al.
Clinical Chemistry|October 3, 1999
Analytical and clinical performance characteristics of Hybritech's Tandem-R free PSA assay during a large multicenter clinical trial to determine the clinical utility of percentage of free prostate-specific antigenD W Chan, C A Kelley, T L Ratliff, et al.
Clinical Biochemistry|September 8, 2014
Diagnostic performance of cardiac Troponin I for early rule-in and rule-out of acute myocardial infarction: Results of a prospective multicenter trialAlan B Storrow, Robert H Christenson, Richard M Nowak, et al.
Pageof 4